IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.044
AS - Asia 3.409
EU - Europa 2.212
SA - Sud America 473
AF - Africa 58
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 26.228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.939
SG - Singapore 1.769
IT - Italia 580
CN - Cina 434
BR - Brasile 380
RU - Federazione Russa 329
HK - Hong Kong 302
VN - Vietnam 281
IE - Irlanda 241
DE - Germania 238
UA - Ucraina 224
FR - Francia 159
GB - Regno Unito 142
BD - Bangladesh 137
KR - Corea 133
JP - Giappone 100
FI - Finlandia 85
NL - Olanda 74
IN - India 56
TW - Taiwan 47
PL - Polonia 46
CA - Canada 45
AR - Argentina 41
MX - Messico 28
AU - Australia 26
SE - Svezia 24
AT - Austria 23
ID - Indonesia 22
IQ - Iraq 21
TR - Turchia 20
ZA - Sudafrica 16
EC - Ecuador 13
ES - Italia 12
CO - Colombia 11
MA - Marocco 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MY - Malesia 9
PH - Filippine 9
CZ - Repubblica Ceca 8
TH - Thailandia 8
VE - Venezuela 8
DZ - Algeria 7
EG - Egitto 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
JM - Giamaica 6
KE - Kenya 6
PE - Perù 6
EU - Europa 5
PY - Paraguay 5
RO - Romania 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
KZ - Kazakistan 4
UY - Uruguay 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
JO - Giordania 3
LB - Libano 3
NI - Nicaragua 3
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SM - San Marino 2
SV - El Salvador 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KG - Kirghizistan 1
KM - Comore 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NG - Nigeria 1
OM - Oman 1
PR - Porto Rico 1
Totale 26.223
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.442
Wilmington 4.709
Houston 3.814
Singapore 889
Fairfield 743
San Jose 484
Ashburn 434
Ann Arbor 413
Chandler 316
Seattle 308
Hong Kong 297
Cambridge 232
Dublin 230
Jacksonville 188
Medford 178
Santa Clara 153
Beijing 148
Council Bluffs 140
Rome 140
New York 129
Los Angeles 109
The Dalles 104
Dearborn 97
Dallas 95
Ho Chi Minh City 89
Lawrence 88
Tokyo 80
Buffalo 78
Hanoi 75
Chicago 66
Lauterbourg 65
Moscow 58
Taipei 42
Menlo Park 36
San Diego 36
Norwalk 35
Kraków 33
São Paulo 33
Milan 31
Munich 29
North Bergen 29
London 25
Nuremberg 25
Salt Lake City 25
Haiphong 20
Redondo Beach 20
Jakarta 18
Lappeenranta 18
Helsinki 17
Orem 17
Mülheim 16
Atlanta 15
Frankfurt am Main 15
Amsterdam 14
Chennai 14
Del Norte 14
Redwood City 14
Rio de Janeiro 14
Elk Grove Village 13
Phoenix 13
Melbourne 12
Montreal 12
Warsaw 12
Boardman 11
Naples 11
Seoul 11
Stockholm 11
Vienna 11
Bologna 10
Lancaster 10
Mexico City 10
Miami 10
Villa Adelina 10
Curitiba 9
Da Nang 9
Denver 9
Johannesburg 9
Mumbai 9
Turin 9
Brooklyn 8
Catania 8
Kuala Lumpur 8
Manchester 8
Modena 8
New Delhi 8
Paris 8
Redmond 8
Ribeirão Preto 8
San Francisco 8
Shanghai 8
Sterling 8
Sydney 8
Tashkent 8
University Center 8
Bethesda 7
Boston 7
Brno 7
Charlotte 7
Falls Church 7
Genoa 7
Totale 21.379
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 538
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 502
Cognitive development in females with PCDH19 gene-related epilepsy 466
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 466
mTOR Inhibitors in Tuberous Sclerosis Complex. 451
Current role of melatonin in pediatric neurology: Clinical recommendations 444
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 442
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 439
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 433
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 430
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 429
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 428
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 424
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 420
Long-term follow-up in children with benign convulsions associated with gastroenteritis 419
The neurobiology of attention deficit/hyperactivity disorder. 416
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 415
Syndromic autism: Causes and pathogenetic pathways 413
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 411
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 407
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 405
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 402
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 397
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 396
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 395
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 392
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 390
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 388
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 388
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 385
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 382
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 381
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 381
The neurobiological basis of ADHD. 380
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 380
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 379
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 377
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 376
Attention deficit hyperactivity disorder in children with epilepsy. 368
MTOR inhibitors as a new therapeutic option for epilepsy 366
Paediatric use of melatonin (Author reply to D. J. Kennaway). 363
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex 357
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 356
Can we change the course of epilepsy in tuberous sclerosis complex? 347
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 345
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 337
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 305
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 300
Pharmacotherapy of idiopathic generalized epilepsies 299
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 294
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 288
Recent advances in neurobiology of Tuberous Sclerosis Complex 273
Autism spectrum disorder and 3p24.3p23 triplication: a case report 255
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 250
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 197
mTOR dysregulation and tuberous sclerosis-related epilepsy 187
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 184
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 179
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 160
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 154
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 147
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 147
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 145
Restless legs syndrome and growing pains in childhood: understanding the link 135
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 134
Sleep-related painful erection: the first case in a child 127
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 126
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 119
Case Report: Migralepsy: The Two-Faced Janus of Neurology 116
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 115
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 114
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 108
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 107
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 104
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 102
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 102
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 101
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 100
Clinical Variability of Pediatric MERS: Insights from a Retrospective Observational Study 99
Autism and epilepsy in patients with Tuberous Sclerosis Complex 99
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 98
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome 93
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 91
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 85
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 84
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 77
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 76
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 75
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 73
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 72
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 71
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions 71
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 70
Sleep Disorders in a Sample of Patients with Pediatric-Onset Multiple Sclerosis: Focus on Restless Legs Syndrome 66
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex 66
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 64
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 63
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 62
TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study 62
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 60
Totale 25.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022729 33 53 28 9 18 62 25 21 159 54 52 215
2022/2023848 96 89 17 81 79 232 87 35 67 3 39 23
2023/2024407 42 9 21 3 28 97 8 3 2 12 96 86
2024/20252.821 57 662 353 153 80 178 140 101 140 452 254 251
2025/20264.516 298 193 482 270 496 141 566 558 492 330 350 340
2026/2027120 120 0 0 0 0 0 0 0 0 0 0 0
Totale 26.589